About Us
Experience
Ellen Goldberg is Founder and President of CHORD Consulting where she works with executives of innovative healthcare companies to develop and commercialize novel products. She has focused her career on ground-breaking technologies in life-threatening and life-altering diseases. As VP of Marketing at Crescendo Bioscience, she launched Ve
Ellen Goldberg is Founder and President of CHORD Consulting where she works with executives of innovative healthcare companies to develop and commercialize novel products. She has focused her career on ground-breaking technologies in life-threatening and life-altering diseases. As VP of Marketing at Crescendo Bioscience, she launched Vectra DA®, a multi-biomarker blood test which enables treatment changes to improve outcomes in rheumatoid arthritis. Prior to Crescendo, Ellen led marketing at Genomic Health, Inc., (now Exact Sciences) where she launched the Oncotype DX® Breast Cancer Assay, a standard of care test which empowers over 80,000 women annually to make better decisions about chemotherapy. While there, she also started the market strategy group, working on pipeline products in DCIS, colon cancer, and prostate cancer, all of which have now been commercialized.
Ellen began her career as a strategy consultant with Booz Allen & Hamilton and developed new products at ALZA Corporation. Ellen has an MS in Chemistry and an MBA from Stanford University and a BS in Chemistry from Yale University. Ellen is a Fellow of the fourth class of the Health Innovators Fellowship Program and a member of the Aspen Global Leadership Network.